Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 5, 2009, Pages 2189-2191

  Cressey, Tim R ^a,c,l   Van Dyke, Russell ^b   Jourdain, Gonzague ^a,c   Puthanakit, Thanyawee ^c   Roongpisuthipong, Anuvat ^d   Achalapong, Jullapong ^e   Yuthavisuthi, Prapap ^f   Prommas, Sinart ^g   Chotivanich, Nantasak ^h   Maupin, Robert ⁱ   Smith, Elizabeth ^j   Shapiro, David E ^a   Mirochnick, Mark ^k  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b TULANE UNIVERSITY   (United States)

^c CHIANG MAI UNIVERSITY   (Thailand)

^d MAHIDOL UNIVERSITY   (Thailand)

^e Chiang Rai Prachanukhao Hospital   (Thailand)

^f PRAPOKKLAO HOSPITAL   (Thailand)

^g BHUMIBOL ADULYADEJ HOSPITAL   (Thailand)

^h CHONBURI HOSPITAL   (Thailand)

ⁱ LOUISIANA STATE UNIVERSITY   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l Program for HIV Prevention and Treatment (PHPT IRD174)   (Thailand)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; LOPINAVIR PLUS RITONAVIR; ZIDOVUDINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG HALF LIFE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAPARTUM CARE; LABOR; MAXIMUM PLASMA CONCENTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THAILAND; TIME TO MAXIMUM PLASMA CONCENTRATION; UNSPECIFIED SIDE EFFECT; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AREA UNDER CURVE; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY TRIMESTER, THIRD; PYRIMIDINONES; RITONAVIR; THAILAND; TREATMENT OUTCOME; YOUNG ADULT;

EID: 66149098490     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01091-08     Document Type: Article

References (7)

1. Chi, B. H., M. Sinkala, F. Mbewe, R. A. Cantrell, G. Kruse, N. Chintu, G. M. Aldrovandi, E. M. Stringer, C. Kankasa, J. T. Safrit, and J. S. Stringer. 2007. Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet 370:1698-1705. (Pubitemid 350100773)
2. Droste, J. A., C. P. Verweij-Van Wissen, and D. M. Burger. 2003. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography. Ther. Drug Monit. 25:393-399. (Pubitemid 36638188)
3. Gibbons, S., D. Back, and S. Khoo. 2007. Variability in lopinavir concentrations in the clinical setting and factors affecting concentrations, abstr. 37. Eighth International Workshop on Clinical Pharmacology of HIV Infection, Budapest, Hungary, April 2007.
4. McIntyre, J., N. Martinson, Investigators for the Trial 1413, V. Boltz, S. Palmer, J. Coffin, J. Mellors, M. Hopley, T. Kimura, P. Robinson, and D. Mayers. 2004. Addition of short course combivir (CBV) to single dose viramune (sdNVP) for prevention of mother-to-child transmission (MTCT) of HIV-1 can significantly decrease the subsequent development of maternal NNRTI-resistant virus, abstr. LbOrB09. XV International AIDS Conference, Bangkok, Thailand, 11 to 16 July 2004.
5. Murphy, R. L., S. Brun, C. Hicks, J. J. Eron, R. Gulick, M. King, A. C. White, Jr., C. Benson, M. Thompson, H. A. Kessler, S. Hammer, R. Bertz, A. Hsu, A. Japour, and E. Sun. 2001. ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS 15:F1-F9. (Pubitemid 32055772)
6. Stek, A. M., M. Mirochnick, E. Capparelli, B. M. Best, C. Hu, S. K. Burchett, C. Elgie, D. T. Holland, E. Smith, R. Tuomala, A. Cotter, and J. S. Read. 2006. Reduced lopinavir exposure during pregnancy. AIDS 20:1931-1939. (Pubitemid 44427610)
7. van der Leur, M. R., D. M. Burger, C. J. la Porte, and P. P. Koopmans. 2006. A retrospective TDM database analysis of interpatient variability in the pharmacokinetics of lopinavir in HIV-infected adults. Ther. Drug Monit. 28:650-653. (Pubitemid 44564064)